Pharmaceuticals

Sartans Market 2026 gaining traction in hypertension management

March 24, 2026March 24, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Sartans Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The sartans market size has demonstrated consistent expansion in recent years. It is anticipated to increase from $22.18 billion in 2025 to $23.09 billion in 2026, registering a compound annual growth rate (CAGR) of 4.1%. This historical growth can be attributed to several factors including the high global hypertension prevalence, the significant burden of cardiovascular disease, the adoption of generic drugs, hospital-based prescribing practices, and the long-term safety profile of sartans.

The size of the sartans market is anticipated to exhibit sustained growth in the coming years. By 2030, this market is projected to reach a value of $27.14 billion, advancing at a compound annual growth rate (CAGR) of 4.1%. Key drivers of this growth over the forecast period encompass an aging demographic, the escalating incidence of kidney disease, a need for economical therapies, the broadening of outpatient treatment options, and the rise of digital pharmacies. Among the prominent trends anticipated in the forecast period are the heightened application in hypertension treatment, the rise of generic angiotensin receptor blockers, a leaning towards combined cardiovascular therapy, the broadening of online pharmacy distribution, and an intensified focus on renal and cardiovascular protective measures.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24393&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Sartans Market?

The increasing occurrence of hypertension is anticipated to fuel the expansion of the sartans market moving ahead. This condition, characterized by sustained elevated blood pressure, significantly increases the risk of developing heart disease, stroke, and other serious medical issues. A diet high in salt and processed foods contributes to the rising incidence of hypertension, leading to fluid retention and added stress on the heart. Sartans function in treating hypertension by inhibiting angiotensin II, a hormone responsible for constricting blood vessels. This action aids in relaxing and expanding the vessels, thereby reducing blood pressure and alleviating the heart’s strain. As an illustration, in September 2025, data from the World Health Organization, an international public health agency based in Switzerland, indicated that approximately 1.4 billion adults globally, aged 30–79 years, had hypertension in 2024, accounting for about 33% of the worldwide population. Consequently, the escalating prevalence of hypertension is propelling the expansion of the sartans market.

What Major Segment Divisions Exist Within The Sartans Market?

The sartans market covered in this report is segmented –

1) By Product Type: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

3) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications

4) By End-User: Hospitals, Other End-Users

Subsegments:

1) By Valsartan: Film-Coated Tablets, Oral Powder Sachets, Triple-Combination Tablets, Ready-To-Use Liquid Formulations

2) By Telmisartan: Soft Gel Capsules, Mouth-Dissolving Strips, Sustained-Release Tablets, Sachet-Packed Granules

3) By Losartan: Chewable Tablets, Pediatric Oral Drops, Effervescent Tablets, Dispersible Tablets

4) By Irbesartan: High-Potency Tablets, Scored Tablets, Hospital Bulk Packs, Blister Strip Packs

5) By Azilsartan: Nanoparticle-Based Tablets, Rapid-Onset Tablets, Unit-Dose Capsules, Microgranule Sachets

6) By Olmesartan: Oral Jelly Formulations, Oral Thin Films, Powder-For-Suspension Packs, Dual-Layer Tablets

How Are Trends Shaping The Direction Of The Sartans Market?

Leading companies in the sartans market are focusing on creating advanced products, such as tablet-form sartans, to enhance treatment efficacy and patient adherence. Tablet-form sartans are oral medications comprising sartan drugs, which function by blocking the effects of angiotensin II, thereby promoting the relaxation of blood vessels and reducing blood pressure. As an illustration, in July 2024, Zydus Lifesciences, an India-based pharmaceutical company, secured US Food and Drug Administration (FDA) approval for Valsartan Tablets USP (40 mg, 80 mg). These tablets are commercially available under the brand name Diovan. They are prescribed to manage hypertension and heart failure, improve survival post-heart-attack in adults, and are also suitable for pediatric patients aged one year and older.

Which Companies Are Leading Innovation In The Sartans Market?

Major companies operating in the sartans market are Viatris Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Unichem Laboratories Ltd., Emcure Pharmaceuticals Ltd., Mylan N.V., Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Ltd., Abbott Laboratories, Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Bayer AG, Merck & Co. Inc.

Read the full sartans market report here:

https://www.thebusinessresearchcompany.com/report/sartans-global-market-report

What Are The Leading Geographic Regions In The Sartans Market?

North America was the largest region in the sartans market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sartans market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Sartans Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24393&type=smp

Browse Through More Reports Similar to the Global Sartans Market 2026, By The Business Research Company

Canned Sardines Market Report 2026

https://www.thebusinessresearchcompany.com/report/canned-sardines-global-market-report

Sarcoma Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/sarcoma-drugs-global-market-report

Pineapples Market Report 2026

https://www.thebusinessresearchcompany.com/report/pineapples-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795